Veriheal

FEBRUARY 11, 2021

The objective of the survey published in December 2020 explored “ the effect that medical cannabis has on prescription opioid medication usage for the treatment of chronic pain at three medical cannabis practice sites ”. The Effect of Medical Cannabis on Prescription Opioids.

Chronic Pain 93

Chronic Pain Patients Clinical Trials Treatment 93

United Patients Group

MARCH 15, 2023

Cannabis is a natural treatment for pain and other symptoms of withdrawal. Cannabis has been shown to be effective in treating chronic pain; it’s also been shown to reduce the amount of opioids needed by patients who take them (and thus reduce side effects). Cannabis can help to manage the side effects of drugs.

Pharmaceutical 98

Pharmaceutical Patients Chronic Pain Sleep 98

The Joint Blog

JUNE 2, 2020

The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. “The 1mg dose showed a significant pain decrease compared to the placebo.

Chronic Pain 58

Chronic Pain Clinical Trials Safety Marijuana 58

Cannabis Law Report

JULY 1, 2021

If you or a loved one suffers from chronic pain, there is a relatively safe alternative to addictive pain pills: cannabis. And, in reality, as the popularity of medical marijuana skyrockets, everyone benefits except the pharmaceutical companies. How Does Cannabis Help?

Chronic Pain 105

Chronic Pain Indica Sativa Strains 105

Kind Meds (Cannabis Education Blog)

JUNE 27, 2021

At the same time, the pharmaceutical industry has become one of the most powerful businesses in the country. Big Pharma, which includes ten of the largest powers of the pharmaceutical industry, like businesses such as Johnson & Johnson, are heavily influential when it comes to political decisions in the U.S. Nerve pain.

Pharmaceutical 99

Pharmaceutical Chronic Pain Medicine Nerve Pain 99

MMJ Recs

MAY 23, 2024

We will be exploring cannabis therapy for chronic conditions. Note that chronic pain refers to the persistent or long-lasting discomfort in the body beyond the normal time frame for healing. The ways chronic pain manifests varies and includes musculoskeletal pain affecting the muscles, bones, ligaments, tendons, and joints.

Conditions 105

Conditions Chronic Pain Therapy Marijuana 105

Cannabis Law Report

SEPTEMBER 9, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 97

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 97

MMJ Recs

JUNE 17, 2024

When dealing with chronic pain, finding relief can be a daily struggle for many people. Traditional pain medications often come with a slew of side effects and may not even provide adequate relief. Medicinal marijuana offers a natural and effective way to manage pain, with fewer adverse effects than traditional medications.

Strains 52

Strains Chronic Pain Indica Sativa 52

Cannabis Law Report

AUGUST 24, 2021

Patent protects methods of administering MYMD-1 for treating disorders associated with chronic inflammation, with a focus on fibrosis and asthma. BALTIMORE–(BUSINESS WIRE)– $MYMD — MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

MMJ Recs

NOVEMBER 17, 2023

The community impact is visible in several key areas: Healthcare Advancements MMJ has expanded the range of treatment options available to patients, offering an alternative to conventional pharmaceuticals. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

DECEMBER 1, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

JANUARY 4, 2022

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. Virpax”), a company specializing in product candidates for pain management, CNS disorders and anti-viral indications, today announced that it will be presenting virtually at the upcoming H.C. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Pharmaceutical 52

Pharmaceutical Research and Development Chronic Pain Events 52

SpeedWeed

APRIL 9, 2021

Eighty percent of all respondents said they were using weed to help with chronic pain, and 52 percent of veteran respondents said they used it for PTSD. . The post 61% of Medical Cannabis Users in Texas Said Weed Helped Them Get off Pharmaceuticals appeared first on SpeedWeed. View original article.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

Cannabis Law Report

SEPTEMBER 22, 2021

New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. We believe that the new data we are revealing today is an extraordinary achievement in the field of pharmaceutical cannabinoids,” said Adam Kaplin, M.D.,

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

PrestoDoctor

DECEMBER 12, 2023

Research has shown that cannabis can help with pain relief, inflammation, nausea, anxiety, and insomnia, among other conditions. Many pharmaceutical drugs come with side effects and the risk of dependency. These have shown to interact with the body’s endocannabinoid system to provide pain relief.

Medicine 98

Medicine Chronic Pain Consumption Pharmaceutical 98

MMJ Recs

MAY 17, 2024

Several factors can also contribute to insomnia, including medical conditions like chronic pain, mental health disorders like anxiety or depression, and lifestyle choices like excessive caffeine or alcohol consumption.

Sleep 105

Sleep Marijuana Chronic Pain Therapy 105

Cannabis Law Report

OCTOBER 5, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it will present at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on Thursday, October 7, 2021.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Media 52

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. As such, patients report reduced reliance on opioids and other pain medications, which often come with severe side effects.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

Leafwell

MAY 5, 2021

When it comes to caring for diseases and the most vulnerable among us, there are some clear areas where modern pharmaceutical medicine fails, and where medical marijuana succeeds.

Chronic Pain 52

Chronic Pain Epilepsy Law Pharmaceutical 52

Cannabis Law Report

OCTOBER 19, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that it will present at the Dawson James Securities 6th Annual Small Cap Growth Conference on Thursday, October 21, 2021, at 4:30 p.m.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

FloridaMarijuana.net

JULY 5, 2018

Chronic Pain. Chronic Pain. GDP’s superior medicinal properties are responsible for appetite stimulation, joint pain and insomnia relief and migraines. This is a heavy indica is known to combat the symptoms of chronic pain and insomnia. Chronic pain. Effects Highlights: Happiness.

Strains 189

Strains Chronic Pain Indica Hybrid 189

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. We continue to enhance our product pipeline, and because of our unique delivery technologies we have expanded our targeted indications beyond pain to include Central Nervous System (CNS) disorders and anti-viral indications. “Our

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

JULY 21, 2021

Director of the Chronic Pain & Fatigue Research Center. ” About Tryp Therapeutics: Tryp Therapeutics is a pharmaceutical company focused on developing psilocybin-based compounds for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. .

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

Cannabis Law Report

OCTOBER 26, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Chapman has operated Chapman Pharmaceutical Consulting, Inc., About MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Canna Care Docs

OCTOBER 3, 2023

However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill. Depending on the type of terminal illness diagnosed by the doctor, there are numerous pharmaceutical and conventional medications provided for patients to treat the symptoms that come with a terminal illness.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

NOVEMBER 23, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

LifeCannMD

AUGUST 30, 2024

Florida’s legalization of medical marijuana in 2016 marked a significant shift in how patients manage chronic conditions. Coconut Grove has embraced this change, with residents increasingly turning to medical cannabis as a natural alternative to traditional pharmaceuticals.

Marijuana 52

Marijuana Chronic Pain Treatment Pharmaceutical 52

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 13, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Cannabis Law Report

DECEMBER 29, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical-stage pharmaceutical company committed to extending healthy lifespan, announced today that its investment company Oravax Medical Inc. Oravax”), partially owned with its majority partner Oramed Pharmaceuticals Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain CBD 52

Cannabis Law Report

NOVEMBER 18, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical-stage pharmaceutical company committed to extending healthy lifespan, announced today that its investment company Oravax Medical Inc. Oravax”), partially owned with its majority partner Oramed Pharmaceuticals Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Chronic Pain 52

Project CBD

SEPTEMBER 12, 2023

He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals. Before long he realized that if he smoked cannabis every couple of hours, his pain eased and he didn’t have to rely as much on doctor-prescribed muscle relaxants, opiates, and benzos to get by. J Clin Med. Neural Plast.

Chronic Pain 228

Chronic Pain Treatment Cannabinoids Research and Development 228

MMJ Recs

JANUARY 13, 2024

“OG Kush,” an Indica-dominant classic, is renowned for its strong body-numbing effects, making it a go-to choice for individuals seeking relief from chronic pain conditions. “Girl Scout Cookies” is a hybrid that combines the best of both worlds, providing potent pain relief along with euphoria and relaxation.

Strains 52

Strains Chronic Pain Indica Sativa 52

Cannabis Law Report

APRIL 22, 2022

It is not a pharmaceutical, and it seems almost perfectly designed to work with the human body. Its interaction with our endocannabinoid system (ECS) is thought to have a number of beneficial effects, just one of which is pain reduction. Those who suffer from chronic pain will know just how debilitating this symptom can be.

Chronic Pain 52

Chronic Pain Oil CBD Tincture 52

SpeedWeed

MARCH 9, 2021

ONE of Germany’s largest pharmaceutical firms has entered the medical cannabis space with the launch of a two flower products – and six more products to follow. Hesse-based Stada, Germany’s fifth largest pharmaceutical company, announced late last year it had entered into an agreement with Canadian firm MediPharm Labs.

Chronic Pain 52

Chronic Pain Business Pharmaceutical Extraction 52

Cannabis Law Report

SEPTEMBER 28, 2021

However, it is a whole different story if someone suffers from serious and chronic pain. In most situations, it is related to another chronic condition that cannot be cured quickly or at all. In this case, the patient needs to look for the best ways to treat pain and improve their life quality. Acupuncture. CBD Products.

Treatment 52

Treatment Chronic Pain Therapy Tincture 52